Viking inks CordenPharma deal to boost obesity drug supply | BioPharma Dive
Dive Brief: - Viking Therapeutics is secure production capacity for its experimental obesity drug, announcing Tuesday it will prepay contract manufacturer CordenPharma $150 million to produce up to 200 million…
Read guide →